Literature DB >> 29302888

Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.

Noble Kumar Talari1, Manas K Panigrahi2, Sailaja Madigubba2, Prakash Babu Phanithi3,4.   

Abstract

Aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor and involved in tumorigenesis of many cancers. However there are no reports on AHR in human meningioma. Therefore we examined the status of the AHR and its signalling molecules in human meningioma by using tumor biopsy samples and autopsy control meninges. We report the up regulation of AHR pathway genes like aryl hydrocarbon receptor nuclear translocator (ARNT), aldehyde dehydrogenase1family memberA3 (ALDH1A3), cytochrome P450, family1, subfamily A polypeptide1 (CYP1A1) and TCCD induced poly ADP ribose polymerase (TIPARP) gene expression in human meningioma. Further, AHR protein expression was found to be up regulated in all grades of human meningioma. We found that AHR localized in the nucleus for high grade anaplastic meningioma through immunohistochemical analysis. Since AHR signalling pathway was known to involve in inhibition of apoptosis in cancer cells, we evaluated the cyclophilin D levels which maintains mitochondrial permeability transition pore a critical event during apoptosis. We report that cyclophilin D levels were upregulated in all grades of human meningioma compared to control meninges. Finally we also evaluated c-Fos protein levels as its levels were regulated by AHR. Here we report that c-Fos protein levels were down regulated in all grades of human meningioma compared to control meninges. To sum-up we found that AHR signalling pathway components were upregulated, as the grade of the meningioma progresses from low to high grade, suggesting an important role of AHR signalling pathway in human meningioma.

Entities:  

Keywords:  Aryl hydrocarbon receptor (AHR); Human meningioma; Indoleamine 2, 3 dioxygenases (IDO); Kynurenine (KYN)

Mesh:

Substances:

Year:  2018        PMID: 29302888     DOI: 10.1007/s11060-017-2730-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

1.  Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor.

Authors:  A Kazlauskas; L Poellinger; I Pongratz
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL.

Authors:  Toshihisa Hayashibara; Yasuaki Yamada; Naoki Mori; Hitomi Harasawa; Kazuyuki Sugahara; Takayuki Miyanishi; Shimeru Kamihira; Masao Tomonaga
Journal:  Biochem Biophys Res Commun       Date:  2003-01-03       Impact factor: 3.575

3.  Altered tryptophan metabolism in human meningioma.

Authors:  Noble Kumar Talari; Manas Panigrahi; Sailaja Madigubba; Sundaram Challa; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2016-07-29       Impact factor: 4.130

4.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

5.  beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Authors:  Udi Gluschnaider; Guy Hidas; Gady Cojocaru; Vladimir Yutkin; Yinon Ben-Neriah; Eli Pikarsky
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.

Authors:  Gang Ding; Weiguo Xu; Hedai Liu; Ming Zhang; Qian Huang; Zhijun Liao
Journal:  Mol Biol Rep       Date:  2013-03-09       Impact factor: 2.316

7.  Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.

Authors:  Masaru Ishida; Shuji Mikami; Eiji Kikuchi; Takeo Kosaka; Akira Miyajima; Ken Nakagawa; Makio Mukai; Yasunori Okada; Mototsugu Oya
Journal:  Carcinogenesis       Date:  2009-09-15       Impact factor: 4.944

Review 8.  The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.

Authors:  Robert Barouki; Xavier Coumoul; Pedro M Fernandez-Salguero
Journal:  FEBS Lett       Date:  2007-03-30       Impact factor: 4.124

9.  Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.

Authors:  Xinhai Yang; Sandra Solomon; Lauren R Fraser; Anthony F Trombino; Donghui Liu; Gail E Sonenshein; Eli V Hestermann; David H Sherr
Journal:  J Cell Biochem       Date:  2008-05-15       Impact factor: 4.429

10.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Authors:  S Mahner; C Baasch; J Schwarz; S Hein; L Wölber; F Jänicke; K Milde-Langosch
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

View more
  8 in total

1.  Genetic analysis of a malignant meningioma and associated metastases.

Authors:  Kristin Huntoon; Ayse Selen Yilmaz; Maciej Pietrzak; Xi Chen; Pearlly Yan; Amanda Ewart Toland; J Bradley Elder
Journal:  Acta Neurochir (Wien)       Date:  2022-01-03       Impact factor: 2.216

Review 2.  Cyclophilin D: Guardian or Executioner for Tumor Cells?

Authors:  Ling Zhang; Yi Liu; Rou Zhou; Baoyu He; Wenjun Wang; Bin Zhang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

3.  A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.

Authors:  Zhongjun Tang; Kebo Cai
Journal:  Anal Cell Pathol (Amst)       Date:  2021-08-14       Impact factor: 2.916

Review 4.  The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors.

Authors:  Maria L Perepechaeva; Alevtina Y Grishanova
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

5.  TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP), A Novel Therapeutic Target Of Breast Cancer.

Authors:  Lin Cheng; Zhi Li; Yu-Zhou Huang; Xu Zhang; Xin-Yuan Dai; Liang Shi; Pei-Wen Xi; Ji-Fu Wei; Qiang Ding
Journal:  Cancer Manag Res       Date:  2019-10-18       Impact factor: 3.989

Review 6.  AhR and Cancer: From Gene Profiling to Targeted Therapy.

Authors:  Anaïs Paris; Nina Tardif; Marie-Dominique Galibert; Sébastien Corre
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

7.  From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis.

Authors:  Jihad Aljabban; Nilay Danis; Merve Gurakar; Kamal Khorfan; Nabeal Aljabban; Cem Simsek; Hussam Salhi; Maryam Panahiazar; Dexter Hadley; Ahmet Gurakar; Behnam Saberi
Journal:  Hepatol Forum       Date:  2020-01-17

8.  Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway.

Authors:  Nada H Eisa; Sakamuri V Reddy; Ahmed M Elmansi; Galina Kondrikova; Dmitry Kondrikov; Xing-Ming Shi; Chad M Novince; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Sadanand Fulzele; William D Hill
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.